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Abstract
The effects of either eicosapentaenoic (EPA)- or docosahexaenoic (DHA)-rich
fish oils on hindlimb suspension (HS)-induced muscle disuse atrophy were
compared. Daily oral supplementations (0.3 mL/100 g b.w.) with mineral oil
(MO) or high EPA or high DHA fish oils were performed in adult rats. After
2 weeks, the animals were subjected to HS for further 2 weeks. The treatments
were maintained alongside HS. At the end of 4 weeks, we evaluated: body
weight gain, muscle mass and fat depots, composition of fatty acids, cross-sec-
tional areas (CSA) of the soleus muscle and soleus muscle fibers, activities of
cathepsin L and 26S proteasome, and content of carbonylated proteins in the
soleus muscle. Signaling pathway activities associated with protein synthesis
(Akt, p70S6K, S6, 4EBP1, and GSK3-beta) and protein degradation (atrogin-
1/MAFbx, and MuRF1) were evaluated. HS decreased muscle mass, CSA of
soleus muscle and soleus muscle fibers, and altered signaling associated with
protein synthesis (decreased) and protein degradation (increased). The treat-
ment with either fish oil decreased the ratio of omega-6/omega-3 fatty acids
and changed protein synthesis-associated signaling. EPA-rich fish oil attenu-
ated the changes induced by HS on 26S proteasome activity, CSA of soleus
muscle fibers, and levels of p-Akt, total p70S6K, p-p70S6K/total p70S6K,
p-4EBP1, p-GSK3-beta, p-ERK2, and total ERK 1/2 proteins. DHA-rich fish
oil attenuated the changes induced by HS on p-4EBP1 and total ERK1 levels.
The effects of EPA-rich fish oil on protein synthesis signaling were more pro-
nounced. Both EPA- and DHA-rich fish oils did not impact skeletal muscle
mass loss induced by non-inflammatory HS.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Introduction
Skeletal muscle mass loss occurs in response to disuse
(e.g., immobilization, denervation or lack of mechanical
load), aging (sarcopenia), starvation, and severe catabolic
states (such as cancer cachexia and sepsis). Muscle atrophy
is associated with a decrease in activity of protein synthesis
and/or an increase in protein degradation signaling. These
two pathways are highly regulated via growth factor effects
and are interrelated (Jackman and Kandarian 2004). Sev-
eral strategies have been investigated to treat skeletal mus-
cle atrophy, including electrical stimulation (Boonyarom
et al. 2009; Dirks et al. 2015), physical exercise (Fujino
et al. 2009; Morimoto et al. 2013; Liu et al. 2014), and
dietary supplementation (e.g., leucine, isoleucine, valine,
creatine, and L-carnitine) (Magne et al. 2013; Wall and
van Loon 2013; de Campos-Ferraz et al. 2014; D’Antona
et al. 2014). Fish oil has been postulated, in review articles,
as a potential attenuating agent of skeletal muscle atrophy
(Magne et al. 2013; Wall and van Loon 2013; D’Antona
et al. 2014). In this study, we investigated the effects of
either eicosapentaenoic (EPA)-rich or docosahexaenoic
(DHA)-rich fish oil on signaling pathways associated with
protein synthesis and degradation in an experimental con-
dition of intense skeletal muscle mass loss.
Fish oil is rich in two omega-3 fatty acids, EPA and
DHA. Fish oils have been reported to reduce severity of
diseases such as diabetes (Yanai et al. 2015), AIDS (Para-
nandi et al. 2014), cancer cachexia (Tisdale 2007), chronic
heart failure (Holdsworth et al. 2014), chronic lung dis-
ease (Miyata and Arita 2015), and sepsis (Gultekin et al.
2014). These diseased conditions are associated with
marked loss of skeletal muscle mass. In vivo treatment
with omega-3 fatty acids increases activity of signaling
pathways associated with protein synthesis (Protein kinase
B [Akt], mammalian target of rapamycin [mTOR], p70
ribosomal protein S6 kinase [p70S6K]) (Gingras et al.
2007; You et al. 2010a,b; Smith et al. 2011a,b; Kamolrat
et al. 2013) and reduces protein degradation (atrogin-1/
muscle atrophy F-box protein [MAFbx], and muscle
RING finger 1 [MuRF1]) (You et al. 2010b). However,
there are relatively few studies on signaling pathways
associated with protein synthesis and degradation in con-
ditions of global skeletal muscle mass loss. A cod liver
oil-rich diet attenuated soleus muscle atrophy in a limb
immobilization animal model (You et al. 2010b). Supple-
mentation with EPA by gavage also attenuated soleus
muscle atrophy in cancer cachexia (Whitehouse et al.
2001). The experimental protocol used to induce skeletal
muscle mass loss in these studies was designed to model
chronic disuse conditions. Comparative effects of DHA-
and EPA-rich fish oils on intracellular signaling have not
been previously investigated.
This study was undertaken to determine the effects of
treatment with high EPA or high DHA fish oils on skele-
tal muscle signaling pathways associated with protein syn-
thesis and degradation in rats submitted to hindlimb
suspension (HS)-induced atrophy. We examined and
compared the effects of EPA- and DHA-rich fish oils on
signaling pathways associated with protein synthesis and
degradation in a condition of intense skeletal muscle mass
loss induced by hindlimb suspension, a model of skeletal




Eight-week-old male Wistar rats were obtained from the
Animal Facility of the Department of Physiology and Bio-
physics, Institute of Biomedical Sciences, University of
S~ao Paulo. The animals were maintained under standard
conditions: light/dark cycle 12 h each and food and water
ad libitum (daily consumption was recorded). All experi-
mental procedures were performed in accordance with
the Guide for Care and Use of Laboratory Animals (Insti-
tute of Laboratory Animal Resources, National Academy
of Sciences, Washington, DC). Ethics Committee of the
Institute of Biomedical Sciences, University of S~ao Paulo,
approved this study.
Experimental study design
During the first 3 days of the experimental period, the
animals were left to adapt to individual cages. Afterwards,
rats were divided into the following groups: mineral oil
supplemented (MO-C, n = 12); mineral oil supplemented
and hindlimb suspension (MO-HS, n = 12); high EPA
fish oil supplemented (EPA-C, n = 12); high EPA fish oil
supplemented and hindlimb suspension (EPA-HS,
n = 12); high DHA fish oil supplemented (DHA-C,
n = 12) and high DHA fish oil supplemented and hin-
dlimb suspension (DHA-HS, n = 12). Rats received a
daily oral supplementation (by gavage) of mineral oil
(MO) or high EPA or high DHA fish oils, 0.3 mL/100 g
b.w., during 4 weeks. The high EPA (68% EPA and 16%
DHA; EPA/DHA ratio 4.3:1) and high DHA (61% DHA
and 11% EPA; EPA/DHA ratio 1:5.7) fish oils were
obtained from Naturalis, S~ao Paulo, Brazil. The fatty
acid composition of the fish oils is in Table 1. Consider-
ing a fish oil density of 0.92 g/cm3, the doses in grams
were: 1.88 mg EPA and 0.44 mg DHA per g b.w. in the
high EPA fish oil and 0.30 mg EPA and 1.68 mg DHA
per g b.w. in the DHA-rich fish oil. The animals were
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submitted to HS from the end of the second week of
treatment on. Rats were then maintained in HS and sup-
plementations with fish oils or mineral oil concomitantly
for 2 weeks to complete the full period of 4-week experi-
mentation. After 4 weeks, animals were anesthetized using
ketamine (90 mg/kg b.w.) and xylazine (10 mg/kg b.w.)
by intraperitoneal administration. Animals were then
weighed and killed by exsanguination. Soleus muscles of
both limbs were removed and stored at 80°C for histo-
logical and molecular analysis. Gastrocnemius, tibialis
anterior, and extensor digitorum longus (EDL) muscles,
as well as subcutaneous, epididymal, retroperitoneal, and
mesenteric adipose tissue depots were removed and
weighed.
Hindlimb suspension
HS is a well-established experimental model for induc-
tion of skeletal muscle mass loss (Morey-Holton and
Globus 2002). Special cages were designed for the hin-
dlimb suspension protocol. The animals were maintained
in individual cages with tail attached on the top of the
cage, using a tape, for suspending the hind limbs (30°
suspension between the floor and the body of the ani-
mal) as reported by others (Thomason et al. 1987;
Morey-Holton and Globus 2002). Suspended animals
were free to walk using the front limbs and to obtain
food and water ad libitum. This experimental model
mimics muscle disuse that occurs in conditions of bed
rest, hospitalization or spaceflight. In order to detect
stress, rat-tail clinical feature, hair, eyes, and facial
appearances of the animals were evaluated twice a day.
In any indication of pain or discomfort of the animals,
the experiment was interrupted (Thomason et al. 1987;
Morey-Holton and Globus 2002). Daily water ingestion
and daily food intake were measured once a week. Body
weight variations were weekly recorded.
Table 1. Fatty acid composition (% of the total fatty acids) of the high EPA and high DHA fish oils. Values are presented as mean  SD of
three determinations.
Fatty acid Name High EPA fish oil High DHA fish oil
14: 0 Myristic — —
16: 0 Palmitic — 1.603  0.097
16: 1 (n-7) Hexadecenoic 0.558  0.034 0.437  0.379
17: 0 Margaric — —
17: 1 (n-7) Heptadecenoic — —
18: 0 Stearic — 1.613  0.037
18: 1 (n-9) Oleic 0.887  0.008 4.779  0.006
18: 1 (n-7) Vaccenic — 1.189  0.029
18: 2 (n-6) Linoleic 0.527  0.047 1.707  0.039
20: 0 Eicosanoic — —
20: 1 (n-9) Eicosenoic — 0.807  0.005
18: 3 (n-6) c-Linolenic — —
18: 3 (n-3) a-Linolenic 0.040  0.034 —
22: 0 Docosanoic 0.025  0.0024 —
20: 2 Eicosadienoic 2.848  0.053 0.800  0.017
20: 3 (n-6) Eicosatrienoic — —
20: 4 (n-6) Arachidonic 2.678  0.043 2.474  0.015
20: 5 (n-3) Eicosapentaenoic 67.695  0.125 10.705  0.045
22: 2 (n-6) Docosadienoic 1.007  0.004 0.780  0.025
24: 1 (n-9) Nervonic — 0.586  0.008
22: 5 (n-6) Docosapentaenoic 0.702  0.026 4.270  0.105
22: 5 (n-3) Docosapentaenoic 3.657  0.079 5.078  0.339
22: 6 (n-3) Docosahexaenoic 15.793  0.592 60.928  0.310
Unidentified 3.647  0.242 3.025  0.421
Totals Saturated — 3.216  0.128
Monounsaturated 1.445  0.037 7.797  0.401
Polyunsaturated 94.907  0.279 85.961  0.594
Omega-6 (3.908  0.064) (8.451  0.078)
Omega-3 (87.145  0.392) (76.711  0.572)
Omega-6/Omega-3 0.045 0.11
EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
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Lipid extraction and determination of the
composition of fatty acids in fish oils and
gastrocnemius muscle by gas
chromatography
The AOAC 996.06 (AOAC, 2005) and AOCS Ce 1j-07
(AOCS, 2007) methods with the C13:0 fatty acid as stan-
dard in place of C11:0 were used. Fatty acid composition
was determined in a GC 2010 plus equipped with auto-
matic sample injector (AOC 20i), flame ionization detec-
tor, GC solution software (Shimadzu Co, Kyoto, Japan),
and 100 m fused silica SP2560 capillary column 0.25 mm
film (Supelco Park, Bellefonte, PA). Composition of fatty
acids of high EPA and high DHA fish oils was expressed
as percentage of total fatty acids from three determina-
tions. The composition of fatty acids in the gastrocnemius
muscle was expressed as g/100 g tissue wet weight
(AOAC, 2005; AOCS, 2007).
Histological analysis of the soleus muscle
Serial sections were performed in the central portion of the
soleus muscles according to Bodine and Baar (2012). The
slides were stained with hematoxylin and eosin (HE) for
analysis of cross-sectional area (CSA) of the whole soleus
muscle and of the soleus muscle fibers (150 fibers per mus-
cle). Photographs were taken using an optical microscope
(Nikon Eclipse E1000, Fukuoka, Japan) attached to a digital
camera (Nixon DXM 1200). The images were analyzed using
the AxioVision program (version 4.8.1.0, Carl Zeiss Imaging
Solutions, Jena, Germany).
Cathepsin L activity measurement
Soleus muscle homogenization and evaluation of cathep-
sin L activity were performed using the Cathepsin L
Activity Assay Kit (Abcam – ab65306, Abcam Inc., Cam-
bridge, UK), according to the recommendations of the
manufacturer and the method described by Jannig et al.
(2014).
26S Proteasome activity determination
Soleus muscles were homogenized in a buffer containing
210 mmol/L D-mannitol, 70 mmol/L sucrose, 5 mmol/L
MOPS, and 1 mmol/L EDTA (pH 7.4). Centrifugation
of the homogenate was performed for 15 min, at
12,000g and 4°C, and the supernatant used for determi-
nation of cytosolic proteins (Bradford 1976). The activity
of the chymotrypsin site of the 26S portion of the pro-
teasome was assessed by fluorometric assay, using the
fluorogenic peptide Suc-Leu-Leu-Val-Tyr-7-amido-4-
methylcoumarin (LLVY-AMC, item #P802-0005, Enzo
Life Sciences, Farmingdale, NY), as described by Church-
ill et al. (2010) and Cunha et al. (2012). Measurements
were performed in the absence and presence of epox-
omicin (20 lmol/L). The difference between the two
rates was attributed to the proteasome activity (Cunha
et al. 2012).
Content of carbonylated proteins in the
soleus muscle
The homogenates of the soleus muscles were prepared as
described above with addition of 2% 2-mercaptoethanol
in the extraction buffer. The OxyBlotTM Protein Oxida-
tion Detection Kit (S7150; Milipore, Billerica, MA) was
used to assess the levels of carbonylated proteins accord-
ing to the recommendations of the manufacturer. Amer-
sham Imager 600 (Amersham/GE Healthcare, Uppsala,
Sweden) was used for image acquisition and the bands
quantitated using the Image J software (NIH, Bethesda,
MD). Total loading of proteins for each sample, as indi-
cated by the Ponceau S staining, was used to normalize
results (Romero-Calvo et al. 2010; Gilda and Gomes
2013; Fortes et al. 2016).
Analysis of Akt, p70S6K, S6, 4EBP1, GSK3-
beta, atrogin-1/MAFbx, MuRF1, and ERK 1/2
by western blot
Soleus muscles were homogenized in a buffer solution
containing 10 mmol/L EDTA, 100 mmol/L Tris-Base,
10 mmol/L sodium pyrophosphate, 100 mmol/L sodium
fluoride, 10 mmol/L sodium orthovanadate, 2 mmol/L
PMSF, and 0.01 mg/mL aprotinin. The samples were then
sonicated for 30 sec at 4°C, treated with 1% Triton X-
100, and centrifuged at 20,000g, at 4°C, for 20 min. The
total content of proteins of the supernatant of each sam-
ple was determined (Bradford 1976). Equal amounts of
protein (40 lg) from each sample were subjected to SDS-
PAGE according to Shapiro et al. (1967). The proteins
were then transferred to a nitrocellulose membrane (Tow-
bin et al. 1979) and had the nonspecific binding sites
blocked by 1-h incubation with 5% milk or 5% BSA solu-
tion.
The membranes were incubated with the primary anti-
bodies for 12 h at 4°C and subsequently incubated for
1 h at 4°C with the secondary antibody conjugated to
peroxidase (Cell Signaling Technology, Beverly, MA).
After treatment with ECL detection reagent (Amersham/
GE Healthcare, Waukesha, WI), the images were captured
by the Amersham Imager 600 (Amersham/GE Healthcare)
and quantified using the Image J software (NIH). Total
loading of proteins for each sample, as indicated by the
Ponceau S staining, was used to normalize the results
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(Romero-Calvo et al. 2010; Gilda and Gomes 2013; Fortes
et al. 2016) expressed in values relative to MO-C. A pool
sample, composed of equal parts of all experimental con-
dition samples, was used for normalization among mem-
branes (Fig. 1). The primary antibodies used were: p-Akt
at Ser 473 (9271), Akt (9272), p-p70S6K at Thr 389
(9205), p70S6K (2708), p-S6 at Ser 240/244 (5364), S6
(2217), p-4EBP1 (eukaryotic translation initiation factor
4E-binding protein 1) at Thr 37/46 (2855), 4EBP1 (9644),
p-GSK3-beta (glycogen synthase kinase3-beta) at Ser 9
(9323), GSK3-beta (9315), p-ERK (extracellular-signal-
regulated kinases 1/2) at Thr 202/Tyr 204 (9101), and
ERK (4695) from Cell Signaling Technology (Danvers,
MA) and atrogin-1 (AP2041) and MuRF1 (MP3401) from
ECM Biosciences (Versailles, KY).
Statistical analysis
Statistical analysis was performed using the GraphPad
Prism software (version 4.01; El Camino Real, CA).
Results are presented as mean  standard error of the
mean (SEM) and were analyzed by two-way analysis of
variance (ANOVA) followed by the Bonferroni post-hoc
test (for comparison between three or more groups).
The differences between groups were considered signifi-
cant for P < 0.05. CSA of the soleus muscle fibers were
not normally distributed, therefore, difference was con-
sidered significant when there was no overlap between
95% CI of the median (Gehrig et al. 2008; Pinheiro et al.
2012).
Results
Water ingestion, food intake, body weight,
muscle wet weights, and fat depots
Daily water ingestion and daily food intake were not sig-
nificantly different among the six groups (data not
shown). The MO-C group had a body weight gain of
156  7.8 g, mean of 10 rats, over 4 weeks. HS reduced
body weight gain in all groups (Table 2).
Wet weights of the soleus, gastrocnemius,
tibialis anterior, and EDL muscles, and of
the subcutaneous, epididymal,
retroperitoneal and mesenteric fat depots
HS reduced soleus muscle mass by approximately 50%
in all groups compared with respective non-HS-treated
animals (P ˂ 0.001) (Table 2). The gastrocnemius mus-
cle mass was also decreased by 26–27% (P ˂ 0.001) in
HS rats compared to non-HS animals. Administration of
Figure 1. Quantitative analysis of western blot membranes stained with Ponceau S. (A) Images of the western blot membranes stained with
Ponceau S used in this study. (B) Average quantitative analysis of Ponceau S staining. No significant differences were observed. The results were
compared using two-way ANOVA and Bonferroni post hoc test. MO, Mineral oil supplementation; EPA, High eicosapentaenoic acid fish oil
supplementation; DHA, High docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension; MO-C, Mineral oil supplemented group;
MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid fish oil supplemented group; EPA-HS,
High eicosapentaenoic acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosahexaenoic acid fish oil supplemented
group; DHA-HS, High docosahexaenoic acid fish oil supplemented and hindlimb suspension group; P, pool containing a mixture with equal
parts of all samples – used to normalize Ponceau S quantitative results; AU, arbitrary units.
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high DHA fish oil (DHA-C) reduced gastrocnemius
muscle mass (normalized by tibia length) as compared
to the MO-C group (P ˂ 0.01). HS reduced (P ˂ 0.001)
tibialis anterior muscle mass in all groups by 13–20% as
compared to non-HS animals. HS also reduced EDL
muscle mass in all groups by 16–20% (Table 2). HS
decreased the subcutaneous fat mass by 22% for MO,
34% for EPA, and 26% for DHA as compared to non-
HS animals. The epididymal fat mass was reduced in
HS rats supplemented with either fish oil; 20% for EPA
and 34% for DHA. HS did not alter the epididymal fat
mass in MO animals. HS caused a decrease of the
retroperitoneal fat mass in rats supplemented with either
fish oil by 51–55% but it did not change in MO rats
(Table 2).
Composition of fatty acids in the
gastrocnemius muscle
Omega-6/omega-3 fatty acid ratio was decreased in the
gastrocnemius muscle from both fish oil supplemented
groups when compared with the MO group (P < 0.001).
The values were: 4  0.4 for MO-C; 4  0.5 for MO-HS;
1  0.1 for EPA-C; 1  0.1 for EPA-HS; 1  0.2 for
DHA-C and 1  0.1 for DHA-HS (data not shown).
Glycogen, protein, and cytokine levels in
soleus muscle
Contents of glycogen, total protein, and cytokines (TNF-
a, IL-1b, IL-6 and IL-10) were measured using standard
Table 2. Body weight and wet weight of skeletal muscles and fat depots.
Groups
MO-C MO-HS EPA-C EPA-HS DHA-C DHA-HS
Body weight
Initial body weight (g) 199  4.5 203  6.2 201  9.9 200  6.6 201  5.7 207  4.0
Increase of body mass after 4 weeks (g) 156  7.8 92  7.0c 136  6.1 80  5.4c 123  7.7y 68  4.2cx
Soleus muscle
Wet weight (mg/mm tibia length) 3.6  0.6 1.8  0.09c 3.5  0.1 1.7  0.07C 3.3  0.02 1.7  0.10c
% Loss due to HS in wet weight 46 0 52 51
Gastrocnemius muscle
Wet weight (mg/mm tibia length) 58  1.3 42  1.1c 55  1.1 40  1.1c 51.9  1.02y 40.0  0.13c
% Loss due to HS in wet weight 27 28 26
Tibialis anterior muscle
Wet weight (mg/mm tibia length) 19  0.5 17  0.7a 18  0.7 15  0.6c 18  0.6 15  0.42c
% Loss due to HS in wet weight 13 18 20
EDL muscle
Wet weight (mg/mm tibia length) 4.2  0.1 3.5  0.1c 4  0.1 3.4  0.1b 4  0.1 3.3  0.1c
% Loss due to HS in wet weight 16 16 20
Subcutaneous fat mass
Wet weight (mg/cm LR) 188  20.1 154  13. 0 198  17.4 138  17.9 177  9.1 139  21.4
% Loss due to HS in wet weight 22 34 26
Epididymal fat mass
Wet weight (mg/cm LR) 125  4.2 142  9.6 130  14.7 109  6.7 136  5.7 93  14.9ay
% Loss due to HS in wet weight 0.7 20 34
Retroperitoneal fat mass
Wet weight(mg/cm LR) 91  15.3 91  11.6 112  13.6 53  8.8bx 95  12.5 49  11.2ax
% Loss due to HS in wet weight 4 55 51
Mesenteric fat mass
Wet weight (mg/cm LR) 181  14.7 161  13.2 215  22.6 139  14.9b 181  12.9 133  12.2
% Loss due to HS in wet weight 15 39 31
Values are presented as mean  SEM, n = 9–12 animals. The results were compared using two-way ANOVA and Bonferroni post hoc test.
aP < 0.05; bP < 0.01; cP < 0.001 for: significant differences between hindlimb suspension groups and the respective controls. xP < 0.05;
yP < 0.01 for: significant differences between the groups supplemented with High EPA or DHA fish oils versus that supplemented with mineral
oil (MO-C vs. EPA/DHA-C or MO-HS vs. EPA/DHA-HS).
MO-C, Mineral oil supplemented group; MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid
fish oil supplemented group; EPA-HS, High eicosapentaenoic acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosa-
hexaenoic acid fish oil supplemented group; DHA-HS, High docosahexaenoic acid fish oil supplemented and hindlimb suspension group; EDL,
extensor digitorum longus; LR, length of the rat.
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methods, but there was no significant difference among
the experimental groups (data not shown).
CSA of the soleus muscle and of soleus
muscle fibers
CSA of the soleus muscle was markedly decreased
(P < 0.001) due to HS in all groups compared to non-HS
animals by 51–57% (Fig. 2A and C). HS also decreased
CSA of the soleus muscle fibers in all groups by 57–61%
(Fig. 2B and D). The treatment with either fish oil modi-
fied HS-induced fiber CSA distribution feature. This
effect, assessed quantitatively by the 95% CI of the med-
ian (Fig. 2D), was supported by qualitative analysis of the
proportion of fibers in different ranges of CSA (Fig. 2E).
Frequency distribution (Fig. 2E) was calculated and
expressed as performed by others (Baehr et al. 2011; Ge
et al. 2011; Kulakowski et al. 2011; Pistilli et al. 2011;
Watson et al. 2012; Callahan et al. 2014). This is an alter-
native way to illustrate the trend of individual results
depicted Figure 2D. Fish oil supplementation during HS
increased the number of fibers in the range of 1000 lm2
by approximately 140% (Fig. 2E). On the other hand,
with respect to fibers in the range of 800 lm2, supple-
mentation with either fish oil during HS caused a reduc-
tion of approximately 25% when compared with MO
animals.
Activities of cathepsin L and 26S
proteasome and content of carbonylated
proteins in the soleus muscle
The cathepsin L activity was not changed due to HS or
supplementation with either fish oil in the soleus muscle
(Fig. 3A). The activity of 26S proteasome was not signifi-
cantly altered by the intragroup analysis (Bonferroni post
hoc test). However, HS increased 26S proteasome activity
(P ˂ 0.05) compared with non-HS animals; 69% for MO
and 31% for DHA (Fig. 3B) as indicated by ANOVA
(with no post hoc test difference). The content of car-
bonylated proteins in the soleus muscle was significantly
changed by experimental conditions of the study as indi-
cated by the Bonferroni post hoc test (MO-C vs. MO-HS;
MO-C vs. EPA-C; MO-C vs. DHA-C, P ˂ 0.01). EPA and
DHA down-regulated carbonylated proteins, but did not
affect HS-induced down-regulation (Fig. 3C).
Protein synthesis-associated signaling in
soleus muscle
The content of p-Akt was reduced due to HS in the MO-
and DHA-rich fish oil groups (MO-C vs. MO-HS; DHA-
C vs. DHA-HS, P ˂ 0.01) (Fig. 4A). HS did not change
the p-p70S6K content although a slight reduction was
found in the three groups: MO: 34%; EPA: 9.8%; DHA:
17% (Fig. 4D). The changes induced by HS in total
p70S6K content (decrease) and p-p70S6K/total p70S6K
ratio (increase) were more pronounced in the MO and
DHA groups (Fig. 4E and F). p-S6 content was reduced
in all groups due to HS; MO: 77%, EPA: 46%, and DHA,
72% (Fig. 4G). A decrease in total S6 and p-S6/total S6
ratio (P ˂ 0.05) due to HS (Fig. 4H and I) was indicated
by ANOVA (with no post hoc test difference). The p-
4EBP1 content was significantly increased (P ˂ 0.05) in
the MO group due to HS but attenuated by either fish
oil; MO: 50%, EPA: 27%, and DHA: 40% (Fig. 4J). A
marked decrease of p-GSK3-beta in response to HS was
observed; MO: 53%, DHA: 42%, and EPA: 37%
(Fig. 4M). The total GSK3-beta content was decreased
due to HS in all groups by 42–48% (Fig. 4N).
Protein degradation-associated signaling in
soleus muscle
The content of atrogin-1/MAFbx and MuRF-1 was not
significantly changed in the intragroup analysis (Bonfer-
roni post-hoc test). However, ANOVA (with no post hoc
test difference) demonstrated that HS resulted in an
increase in these proteins; MO: 39%, EPA: 60%, and
DHA: 14% for atrogin-1/MAFbx and MO: 22%, EPA:
17%, and DHA: 29% for MuRF-1 (Fig. 5A and B).
Changes in phosphorylated and total ERK 1
and 2 in soleus muscle
HS reduced p-ERK 1 content (P < 0.05) in soleus muscle
of the DHA-treated group. The decrease in p-ERK 1 con-
tent induced by HS was less pronounced following EPA
fish oil administration (MO: 38%; EPA: 26%; DHA:
47%) (Fig. 6A). The total ERK 1 content was significantly
decreased in the MO group due to HS (MO-C vs. MO-
HS, P ˂ 0.05). This latter effect was attenuated by treat-
ments with either fish oil (MO: 42%; EPA: 16%; DHA:
27%) (Fig. 6B). HS decreased the contents of p-ERK 2
and total ERK 2 proteins in the MO and DHA groups
(P ˂ 0.05). The decrease in p-ERK 2 (MO: 69%; EPA:
39%; DHA: 50%) and total ERK 2 (MO: 69%; EPA: 27%;
DHA: 31%) induced by HS was more pronounced in the
MO group and only EPA treatment resulted in significant
attenuation (Figs. 6D and E).
Discussion
The level of skeletal muscle atrophy induced by HS varies
with the type of muscle fiber affected and the length of
treatment. Muscles predominantly made up of oxidative/
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slow twitch/type I fibers are associated with greater mass
loss due to gravity withdrawn as in HS (Fitts et al. 2000;
Bederman et al. 2013; Bodine 2013; Ciciliot et al. 2013).
We have described greater effects of HS on soleus muscle
that is composed mainly of oxidative/slow twitch/type I
fibers (Soukup et al. 2002) and has anti-gravitational roles
(Bodine 2013). The HS effects were less pronounced in
muscles with predominance of glycolytic/fast twitch/type
II fibers. The level of muscle atrophy induced by HS was
(greatest to weakest effect): soleus > gastrocnemius > tib-
ialis anterior > EDL. These findings are in agreement with
previous studies (Thomason & Booth 1990; Maki et al.
2012; Bodine 2013). Andrianjafiniony et al. (2010)
reported a reduction of 41% in soleus muscle mass of
Wistar rats induced by HS for 14 days, similar to this
study (46%).
There was no marked effect of either fish oil on skeletal
muscle mass preservation in this study, which may reflect
the long duration of the HS protocol (high level of mus-
cle atrophy), absence of inflammation, dose of fish oils
used, and/or short period of supplementation. The benefi-
cial effects of fish oil on skeletal muscle mass were
Figure 3. (A) The cathepsin L activity in soleus muscle (B) 26S proteasome activity in soleus muscle, (C) content of carbonylated proteins of
soleus muscle and (D) representative image of the western blotting analysis of carbonylated proteins (55 KDa-130 KDa). Values are presented
as mean  SEM on the basis of total protein loading as indicated by the Ponceau S measurement, n = 6–8 animals. The results were compared
using two-way ANOVA and Bonferroni post hoc test. MO, Mineral oil supplementation; EPA, High eicosapentaenoic acid fish oil
supplementation; DHA, High docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension; MO-C, Mineral oil supplemented group;
MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid fish oil supplemented group; EPA-HS,
High eicosapentaenoic acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosahexaenoic acid fish oil supplemented
group; DHA-HS, High docosahexaenoic acid fish oil supplemented and hindlimb suspension group; AU, arbitrary units.
Figure 2. Cross-sectional areas (CSA) of the soleus muscle and soleus muscle fibers. (A) Representative histological hematoxylin and eosin
staining images of cross-sectional areas of the soleus muscle. a. MO-C; b. MO-HS; c. EPA-C; d. EPA-HS; e. DHA-C; f. DHA-HS. Reference bar
represents 100 lm. (B) Representative histological hematoxylin and eosin staining images of cross-sectional areas of soleus muscle fibers; a.
MO-C; b. MO-HS; c. EPA-C; d. EPA-HS; e. DHA-C; f. DHA-HS. Reference bar represents 100 lm. (C) Cross-sectional area of the soleus muscle.
Values are presented as mean  SEM, n = 5–8 animals. The results were compared using two-way ANOVA and Bonferroni post hoc test. (D)
Cross-sectional areas of soleus muscle fibers. Values are presented as scatter plot with median, n = 750–1199. The results were analyzed as
previously described using the 95% CI of the median. (E) Distribution of the soleus muscle fibers according to the ranges of the areas of soleus
muscle fibers: 0–2800 lm2. MO-C, Mineral oil supplemented group; MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C,
High eicosapentaenoic acid fish oil supplemented group; EPA-HS, High eicosapentaenoic acid fish oil supplemented and hindlimb suspension
group; DHA-C, High docosahexaenoic acid fish oil supplemented group; DHA-HS, High docosahexaenoic acid fish oil supplemented and
hindlimb suspension group; MO, Mineral oil supplementation; EPA, High eicosapentaenoic acid fish oil supplementation; DHA, High
docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension. O, difference between groups.
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Figure 4. Contents of proteins associated with signaling pathway protein synthesis in the soleus muscle: (A) p-Akt, (B) total Akt, (C) p-Akt/Akt
total ratio, (D) p-p70S6k, (E) total p70S6k, (F) p-p70S6k/p70S6k total ratio, (G) p-S6, (H) total S6, (I) p-S6/S6 total ratio, (J) p-4EBP1, (K) total
4EBP1, (L) p-4EBP1/4EBP1 total ratio, (M) p-GSK3-beta, (N) total GSK3-beta, (O) p-GSK3-beta/total GSK3-beta ratio. Values are presented as
mean  SEM on the basis of total protein loading as indicated by the Ponceau S measurements and expressed relative to MO-C, n = 6–8
animals. The results were compared using two-way ANOVA and Bonferroni post hoc test. MO, Mineral oil supplementation; EPA, High
eicosapentaenoic acid fish oil supplementation; DHA, High docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension; MO-C,
Mineral oil supplemented group; MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid fish oil
supplemented group; EPA-HS, High eicosapentaenoic acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosahexaenoic
acid fish oil supplemented group; DHA-HS, High docosahexaenoic acid fish oil supplemented and hindlimb suspension group.
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Figure 5. Contents of proteins associated with signaling pathway of protein degradation in the soleus muscle: (A) atrogin-1/MAFbx, (B) MuRF-
1, (C) representative images of the western blotting analysis of atrogin-1/MAFbx and MuRF-1. Values are presented as mean  SEM on the
basis of total protein loading as indicated by the Ponceau S measurement and expressed relative to MO-C, n = 7–8 animals. The results were
compared using two-way ANOVA and Bonferroni post hoc test. MO, Mineral oil supplementation; EPA,High eicosapentaenoic acid fish oil
supplementation; DHA, High docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension; MO-C, Mineral oil supplemented group;
MO-HS, Mineral oil supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid fish oil supplemented group; EPA-HS,
High eicosapentaenoic acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosahexaenoic acid fish oil supplemented
group; DHA-HS, High docosahexaenoic acid fish oil supplemented and hindlimb suspension group.
Figure 6. Contents of phosphorylated and total ERK 1 and 2 proteins in the soleus muscle: (A) p-ERK 1, (B) total ERK 1, (C) p-ERK 1/total ERK
1 ratio, (D) p-ERK 2, (E) total ERK 2, (F) p-ERK 2/total ERK 2 ratio. Values are presented as mean  SEM on the basis of total protein loading as
indicated by the Ponceau S measurements and expressed relative to MO-C, n = 7–8 animals. The results were compared using two-way
ANOVA and Bonferroni post hoc test. MO, Mineral oil supplementation; EPA, High eicosapentaenoic acid fish oil supplementation; DHA, High
docosahexaenoic acid fish oil supplementation; HS, hindlimb suspension; MO-C, Mineral oil supplemented group; MO-HS, Mineral oil
supplemented and hindlimb suspension group; EPA-C, High eicosapentaenoic acid fish oil supplemented group; EPA-HS, High eicosapentaenoic
acid fish oil supplemented and hindlimb suspension group; DHA-C, High docosahexaenoic acid fish oil supplemented group; DHA-HS, High
docosahexaenoic acid fish oil supplemented and hindlimb suspension group.
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reported in inflammation-associated muscle wasting con-
ditions as in cancer cachexia (Whitehouse et al. 2001; Tis-
dale 2007).
Oral supplementation of high EPA and high DHA fish
oils markedly changed composition of fatty acids in gas-
trocnemius muscle. Decreased omega-6 fatty acid and
increased omega-3 fatty acid levels that resulted in reduc-
tion of omega-6/omega-3 fatty acid ratio were also
reported in previous studies (Hutchins-Wiese et al. 2012).
HS caused a marked decrease in body weight as also
observed by Hirose et al. (2008) in Wistar rats and Maki
et al. (2012) in Sprague–Dawley rats. Animals submitted
to HS initially have signs of stress because they are moved
from a collective environment to an individual cage,
which requires an adaptation period (Morey-Holton and
Globus 2002; Tsvirkun et al. 2012; Hanson et al. 2013).
Control animals have then to be kept under identical
cages and conditions (Morey-Holton and Globus 2002).
Herein, we followed the recommendations of the authors
of previous studies (Thomason et al. 1987; Morey-Holton
and Globus 2002).
HS reduced fat mass as also previously reported by
others (Hutchins-Wiese et al. 2012; Lloyd et al. 2014).
Hutchins-Wiese et al. (2012) described HS for 2 weeks
decreases epididymal fat mass in mice. They did not
report changes in epididymal fat mass by the dietary con-
ditions studied: control, moderate, and high omega-3
fatty acid intake. Omega-3 fatty acids have been reported
to reduce fat mass in several animal experimental models
(Belzung et al. 1993; Baillie et al. 1999; Perez-Matute
et al. 2007; Buckley and Howe 2009) and humans (Parra
et al. 2008; Buckley and Howe 2009; Bender et al. 2014;
Moosheer et al. 2014). Herein, the decrease in the weight
of epididymal, retroperitoneal, and mesenteric fat depots
induced by HS was more pronounced following fish oil
treatment as compared to mineral oil.
The CSA of the soleus muscle was decreased by more
than 50% due to HS in all groups. Derbre et al. (2012)
reported similar results in soleus muscle from rats sub-
mitted to HS for 14 days. HS also decreased CSA of the
soleus muscle fibers and altered fiber CSA profile. Similar
effect was reported by others (Andrianjafiniony et al.
2010; Maki et al. 2012; Liu et al. 2014). The results of
muscle fiber CSA as described in Figure 2D (with indica-
tions of statistical significance) were also presented as fre-
quency distribution in Figure 2E. Despite the limitations
of the frequency distribution analysis, muscle disuse
induced a marked decrease in muscle fiber CSA as
expected. The treatments with both fish oils partially
attenuated the trend to decrease muscle fiber area induced
by HS. This statement is based on the increased propor-
tion of muscle fibers with 1000 lm2 and a decrease of
muscle fibers with 800 lm2 as a result of fish oil
treatments in rats with HS. Although immunohistochem-
istry for type I and type II muscle fibers was not per-
formed in this study, hindlimb suspension animal model
has been reported to promote a decrease in the percent-
age of type I muscle fibers and an increase of type II
muscle fibers (Caiozzo et al. 1997; Baldwin et al. 2013).
So, the decrease in muscle fiber CSA induced by HS
reported in this study parallels with the increase in type II
muscle fibers described by others.
Cathepsin L activity, which indicates lysosomal proteol-
ysis, is increased in skeletal muscle in disuse (Bechet et al.
2005). Taillandier et al. (1996) reported increased cathep-
sin L activity in rats submitted to HS for 9 days. Herein,
no change in cathepsin L activity was observed probably
due to the fact protein degradation intensity approaches
control values after 14 days of HS (Hanson et al. 2013;
Lloyd et al. 2014; Bodine et al. 2001). There are few stud-
ies on 20S and/or 26S portions of the ubiquitin protea-
some system in HS (Bodine 2013). HS increased 26S
proteasome and ubiquitin ligases, as atrogin-1/MAFbx
and MuRF1. The content of carbonylated proteins was
reduced due to HS in MO rats. Treatments with fish oils,
regardless HS, decreased the content of carbonylated pro-
teins but did not promote further reduction when given
to HS animals. An inverse relationship between protea-
some activity and contents of carbonylated proteins has
been reported (Cunha et al. 2012). Increased proteasome
activity promotes degradation of misfolded proteins
decreasing carbonylated protein levels. Derbre et al.
(2012) did not report similar effects to those described in
this study. The authors reported increased content of car-
bonylated protein in rat skeletal muscle after being sus-
pended for 14 days. This difference may be due to the
range of protein molecular weight investigated. Herein,
proteins in the 55–130 KDa range were studied; similar
used by others (Cunha et al. 2012).
HS decreases activity of signaling associated with pro-
tein synthesis and increases signaling associated with pro-
tein degradation (Bodine et al. 2001; Derbre et al. 2012;
Maki et al. 2012; Bodine 2013; Liu et al. 2014; Lloyd
et al. 2014). HS for 3 and 7 days progressively decreased
Akt and S6 levels (Cannavino et al. 2014). On the other
hand, at 7, 14, and 21 days of HS, there was a decrease in
the activity of total protein synthesis and levels of S6 and
4EBP1 (Lloyd et al. 2014) in skeletal muscle. The
decreased content of p-Akt and total p70S6K induced by
HS was partially reversed by treatment with high EPA fish
oil. Fish oil promotes anabolism by enhancing insulin
sensitivity and by activating the Akt-mTOR-S6 signaling
pathway (Gingras et al. 2007). Akt also promotes GSK3-
beta phosphorylation that in turn attenuates the inhibi-
tion of eIF2B (eukaryotic initiation factor 2B) activity, so
resulting in an increase of protein synthesis. We report
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herein a decrease of GSK3-beta phosphorylation due to
HS that was more pronounced in the high DHA fish oil
group as compared to high EPA.
Changes in cell fatty acid composition impact on mus-
cle cell proliferation and differentiation by modulating
the activity of MAPKs (JNK 1/2, p38 and ERK 1/2) (Lee
et al. 2009). Activation of JNK 1/2 and p38 and inhibi-
tion of ERK 1/2 have been postulated to occur during
HS, which may be associated with induction of cell apop-
tosis during disuse-induced muscle atrophy (Powers et al.
2007). Activation of p38 has been reported after two
(Derbre et al. 2012) and three (Liu et al. 2014) weeks of
HS. Increases of p-ERK1 content and of p-ERK2/total
ERK2 ratio in mice soleus muscle after 3 weeks of HS
have also been described (Liu et al. 2014). Supplementa-
tion with high EPA fish oil attenuated the decrease in the
contents of phosphorylated and total ERK 1/2 induced by
HS. However, little is known about ERK1/2 activation in
skeletal muscle under such conditions (Powers et al.
2007). Contents of JNK 1/2 and p38 were not signifi-
cantly different among the groups following treatment
with either fish oil (data not shown).
You et al. (2010b) added cod liver oil to the diet of
Sprague–Dawley rats during 2 weeks before inducing
muscle atrophy for 10 days through leg immobilization
(“local muscle atrophy”). The authors found an increase
of atrogin-1/MAFbx and MuRF1 contents and a decrease
of p-Akt/total Akt and of p-p70S6K/total p70S6K ratios
in MO rats, whereas fish oil-enriched diet attenuated
soleus muscle atrophy. The effect of reloading for 3 and
13 days after the period of leg immobilization was also
investigated (2010a). The authors reported fish oil inhibits
initial state of recovery after disuse by suppressing activa-
tion of the Akt-p70S6K pathway and by reducing PGF2a
content (2010a). Fappi et al. (2014) concluded that oral
supplementation with fish oil (high EPA) in dexametha-
sone-induced muscle atrophy has no positive effect. On
the contrary, fish oil increased the expression of atrogenes
(atrogin-1/MAFbx and MuRF1) and reduced that of myo-
genin.
Differences were observed between the effects of the high
EPA and high DHA fish oils in this study. High EPA fish
oil decreased retroperitoneal fat depot and modulated the
effects of HS on p-Akt, total p70S6K, p-p70S6K/total
p70S6K ratio, p-4EBP1, p-GSK3-beta, p-ERK1, p-ERK2,
total ERK1, and total ERK2. High DHA fish oil per se
attenuated body weight gain over 4 weeks and caused a
reduction in gastrocnemius muscle mass, epididymal and
retroperitoneal fat depots and attenuated changes induced
by HS on p-4EBP1 and total ERK1 levels. Therefore, the
effects of EPA-rich fish oil on signaling pathways associated
with protein synthesis were clearly more pronounced than
those by DHA-rich fish oil. Both EPA- and DHA-rich fish
oils did not exhibit marked effect on skeletal muscle mass
loss induced by HS under the conditions of this study.
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